Biovectra Enhances Manufacturing Capacity and Flexibility with ABEC’s CSR® Large-Scale, Single-Use Microbial Fermentation Technology 22nd September 2021
ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing and BIOVECTRA, a CDMO specializing in clinical-to-commercial scale production of high-quality regulated Biologics, Active Pharmaceutical Ingredients, and intermediates, today announced ABEC will design, manufacture, and install CSR single-use microbial fermentation solutions at BIOVECTRA’s manufacturing facility in Windsor, Nova Scotia, Canada. ABEC’s fast-track manufacturing schedule will enable BIOVECTRA to be fully operational by Q2, 2022.
The seamless integration of ABEC CSR single-use fermentation solutions will enhance BIOVECTRA’s high growth microbial fermentation processes and provide fast turnaround product to product and between batches. The addition of large-scale single-use fermentation capability provides BIOVECTRA customers with greater flexibility, faster turnaround and higher capacity utilization. ABEC is also supplying BIOVECTRA CSR single-use disposable containers (DCs) from its two in-house ISO-7 cleanroom manufacturing facilities in Bethlehem, Pa. and Fermoy, County Cork, Ireland. These facilities, as well as ABEC’s qualification of multiple single-use instrument and component suppliers, ensure a robust supply chain and timely delivery to meet BIOVECTRA’s rapid time to market needs.
“BIOVECTRA will be the first Canadian CDMO to offer single-use, microbial fermentation at 1,000L scale,” said Heather Delage, Chief Commercial Officer, BIOVECTRA. “ABEC’s 100L and 1,000L fermentation suites, complement our fixed asset base in biologics fermentation, bringing our customers improved economies of scale and greater process flexibility.”
“ABEC continues to lead the industry advancing bioprocess manufacturing with large-scale single-use process solutions,” said Scott Pickering, ABEC CEO and Chairman. “We are excited to help BIOVECTRA expand their capability, offering single-use, microbial fermentation at large-scale, and we look forward to supporting their continued success.”